Thanks Mr. Montanus !(correct post) Clarification to new shareholders: SHIRE Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia https://clinicaltrials.gov/ct2/show/NCT01898884?term=Friedreich%E2%80%99s+Ataxia+shire&rank=1 -------------------------------------------------------------- We can imagine what would be the pps if Shire will pay the first milestone of $ 10 million, as Mr. Bing wrote ! I hope that the usual "SHORTER" does not intervene to stop the price at the current level ... .-